Furthermore, in both monotherapy and combination groups, RARA knockdown resulted in reduced tumor volume and weight, an effect that was reversed by overexpression of TXN and PPM1F, which was consistent with vitro experiments (Fig. 7d–f). Here, RARA is linked to neoplasm.